What drives a clinical trial investigator? The chance to support progress in science for patients. | Regeneron

🌟 Did you know? Cutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer, with an estimated 1.8 million cases diagnosed each year in the U.S. – and continues to be on the rise. People with CSCC with a high risk of recurrence have a greater chance of the cancer coming back after treatment, which is why identification of high-risk features is so important. Stay informed, prioritize skin health and consult a healthcare provider for regular check-ups. ✅ | Regeneron

À seulement 18 ans, Matteo Paz remporte le prestigieux concours Regeneron Science Talent Search pour sa découverte de 1,5 million d’objets cachés dans l’univers. Abonne-toi pour ➕ d’initiatives positives ! 🍀 | Le Média Positif